Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach.
Authors
Schouten, Erik JJahn, Andreas
Midiani, Dalitso
Makombe, Simon D
Mnthambala, Austin
Chirwa, Zengani
Harries, Anthony D
van Oosterhout, Joep J
Meguid, Tarek
Ben-Smith, Anne
Zachariah, Rony
Lynen, Lutgarde
Zolfo, Maria
Van Damme, Wim
Gilks, Charles F
Atun, Rifat
Shawa, Mary
Chimbwandira, Frank
Affiliation
Department of HIV and AIDS, Ministry of Health, Lilongwe, Malawi. eschouten@msh.orgIssue Date
2011-07-16
Metadata
Show full item recordJournal
LancetPubMed ID
21763940Language
enISSN
1474-547Xae974a485f413a2113503eed53cd6c53
10.1016/S0140-6736(10)62303-3
Scopus Count
Collections
Related articles
- Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
- Authors: Kesho Bora Study Group., de Vincenzi I
- Issue date: 2011 Mar
- Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
- Authors: Tonwe-Gold B, Ekouevi DK, Viho I, Amani-Bosse C, Toure S, Coffie PA, Rouet F, Becquet R, Leroy V, El-Sadr WM, Abrams EJ, Dabis F
- Issue date: 2007 Aug
- [Antiviral agents for reduction of mother-to-child transmission of HIV infection].
- Authors: Bruun JN
- Issue date: 2003 Aug 14
- A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.
- Authors: Moodley D, Moodley J, Coovadia H, Gray G, McIntyre J, Hofmyer J, Nikodem C, Hall D, Gigliotti M, Robinson P, Boshoff L, Sullivan JL, South African Intrapartum Nevirapine Trial (SAINT) Investigators.
- Issue date: 2003 Mar 1
- Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
- Authors: Taha TE, Kumwenda J, Cole SR, Hoover DR, Kafulafula G, Fowler MG, Thigpen MC, Li Q, Kumwenda NI, Mofenson L
- Issue date: 2009 Nov 15